Meijuan Tu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Circadian fluctuation of soluble CD26 dictates the impact of the timing of cord blood transplantation on acute graft-versus-host disease.
Journal: Nature communications
Published: June 12, 2025
Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial.
Journal: Experimental hematology & oncology
Published: May 26, 2025
Developing a Competency Assessment Index System for Hematology Nurses in China: Delphi Study Insights.
Journal: Clinical nurse specialist CNS
Published: February 19, 2025
Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study.
Journal: Transplantation and cellular therapy
Published: May 18, 2024
The Clinical Influence of Complete Remission With Incomplete Count Recovery (CRi) on Single-Unit Unrelated Cord Blood Transplantation in Patients With Acute Leukemia.
Journal: Transplantation and cellular therapy
Published: April 29, 2024
A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation.
Journal: Stem cell research & therapy
Published: October 27, 2022
Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
Journal: Stem cell research & therapy
Published: May 05, 2022
The clinical influence of preformed nonspecific anti-HLA antibodies on single-unit umbilical cord blood transplantation in patients with haematological malignancies.
Journal: British journal of haematology
Published: April 25, 2022
Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation.
Journal: iScience
Published: March 28, 2022
Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study.
Journal: American journal of hematology
Published: November 15, 2021
Chimeric Antigen Receptor T Cell Therapy followed by Unrelated Cord Blood Transplantation for the Treatment of Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia in Children and Young Adults: Superior Survival but Relatively High Post-Transplantation Relapse.
Journal: Transplantation and cellular therapy
Published: August 14, 2021
Last Updated: 09/26/2026